Aims: Anemia of inflammation is quite prevalent in hospitalized patients with poor prognosis. Concerns about the effectiveness and safety of iron supplementation have arisen, driving the demand for alternative therapies. Induction of hepatic hepcidin, the master hormone of iron homeostasis, causes anemia under inflammatory conditions. Previous studies indicated that hydrogen sulfide (H2S), the third gasotransmitter and a well-known regulator of inflammation, may inhibit the secretion of inflammatory cytokines. We thus investigated the effect of H2S on inflammatory hepcidin induction. Results: H2S suppressed lipopolysaccharide (LPS)-induced hepcidin production and regulated iron homeostasis in mice by decreasing serum interleukin-6 (IL-6) and Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) activation; similar results were obtained in Huh7 cells exposed to conditioned medium from LPS-challenged THP-1 macrophages. Intriguingly, we found H2S also attenuated hepcidin levels in Huh7 cells and mouse primary hepatocytes in a sirtuin 1 (SIRT1)-dependent manner. By promoting SIRT1 expression and stabilizing SIRT1-STAT3 interactions, H2S ameliorated IL-6-induced STAT3 acetylation, resulting in reduced hepcidin production. Inhibition and silencing of SIRT1 diminished H2S-mediated suppression of hepcidin, as opposed to SIRT1 activation and overexpression. Consistent results were observed in vivo. Furthermore, knockout of cystathionine γ-lyase (CSE), an endogenous H2S synthase, exaggerated inflammatory hepcidin expression in mice. Innovation: For the first time, we elucidated the effects and possible mechanisms of H2S on inflammatory hepcidin and established a novel regulatory link between SIRT1 and hepcidin. Conclusion: Our work demonstrates that H2S attenuates inflammation-induced hepatic hepcidin via multipathways and suggests new treatment strategies for anemia of inflammation. Antioxid. Redox Signal. 24, 70–83.
Get full access to this article
View all access options for this article.
References
1.
AggarwalBB, KunnumakkaraAB, HarikumarKB, GuptaSR, TharakanST, KocaC, DeyS, and SungB. Signal transducer and activator of transcription-3, inflammation, and cancer. Ann N Y Acad Sci, 1171: 59–76, 2009.
2.
ArmitageAE, EddowesLA, GileadiU, ColeS, SpottiswoodeN, SelvakumarTA, HoL-P, TownsendAR, and DrakesmithH. Hepcidin regulation by innate immune and infectious stimuli. Blood, 118: 4129–4139, 2011.
3.
BeckerS, GronerB, and MüllerCW. Three-dimensional structure of the Stat3β homodimer bound to DNA. Nature, 394: 145–151, 1998.
4.
BlanderG and GuarenteL. The Sir2 family of protein deacetylases. Annu Rev Biochem, 73: 417–435, 2004.
5.
BoutantM and CantóC. SIRT1 metabolic actions: integrating recent advances from mouse models. Mol Metab, 3: 5–18, 2014.
6.
DarnellJE. Transcription factors as targets for cancer therapy. Nat Rev Cancer, 2: 740–749, 2002.
7.
DasguptaM, UnalH, WillardB, YangJ, KarnikSS, and StarkGR. Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3. J Biol Chem, 289: 30763–30771, 2014.
8.
DuJ, HuangY, YanH, ZhangQ, ZhaoM, ZhuM, LiuJ, ChenSX, BuD, and TangC. Hydrogen sulfide suppresses oxidized low-density lipoprotein (ox-LDL)-stimulated monocyte chemoattractant protein 1 generation from macrophages via the nuclear factor κB (NF-κB) pathway. J Biol Chem, 289: 9741–9753, 2014.
9.
FalzacappaMVV, SpasicMV, KesslerR, StolteJ, HentzeMW, and MuckenthalerMU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood, 109: 353–358, 2007.
10.
GanzT. Hepcidin in iron metabolism. Curr Opin Hematol, 11: 251–254, 2004.
11.
GanzT. Hepcidin and iron regulation, 10 years later. Blood, 117: 4425–4433, 2011.
12.
GanzT and NemethE. Hepcidin and iron homeostasis. Biochim Biophys Acta, 1823: 1434–1443, 2012.
13.
GaoR, ChenJ, HuY, LiZ, WangS, ShettyS, and FuJ. Sirt1 deletion leads to enhanced inflammation and aggravates endotoxin-induced acute kidney injury. PLoS One, 9: e98909, 2014.
14.
HegdeA and BhatiaM. Hydrogen sulfide in inflammation: friend or foe?. Inflamm Allergy Drug Targets, 10: 118–122, 2011.
15.
KauppinenA, SuuronenT, OjalaJ, KaarnirantaK, and SalminenA. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal, 25: 1939–1948, 2013.
16.
KemnaE, PickkersP, NemethE, van der HoevenH, and SwinkelsD. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood, 106: 1864–1866, 2005.
17.
KingAL, PolhemusDJ, BhushanS, OtsukaH, KondoK, NicholsonCK, BradleyJM, IslamKN, CalvertJW, and TaoY-X. Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent. Proc Natl Acad Sci U S A, 111: 3182–3187, 2014.
18.
KrauseA, NeitzS, MägertH-J, SchulzA, ForssmannW-G, Schulz-KnappeP, and AdermannK. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett, 480: 147–150, 2000.
19.
LagougeM, ArgmannC, Gerhart-HinesZ, MezianeH, LerinC, DaussinF, MessadeqN, MilneJ, LambertP, and ElliottP. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell, 127: 1109–1122, 2006.
20.
LawenA and LaneDJ. Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action. Antioxid Redox Signal, 18: 2473–2507, 2013.
21.
LeeP, PengH, GelbartT, and BeutlerE. The IL-6-and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and β2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A, 101: 9263–9265, 2004.
22.
LiL, BhatiaM, ZhuYZ, ZhuYC, RamnathRD, WangZJ, AnuarFBM, WhitemanM, Salto-TellezM, and MoorePK. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J, 19: 1196–1198, 2005.
23.
LiM, LuoJ, BrooksCL, and GuW. Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem, 277: 50607–50611, 2002.
24.
LiX, ZhangK-Y, ZhangP, ChenL-X, WangL, XieM, WangC-Y, and TangX-Q. Hydrogen sulfide inhibits formaldehyde-induced endoplasmic reticulum stress in PC12 cells by upregulation of SIRT-1. PLoS One, 9: e89856, 2014.
25.
LinR, TaoR, GaoX, LiT, ZhouX, GuanK-L, XiongY, and LeiQ-Y. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol Cell, 51: 506–518, 2013.
26.
MalikenBD, NelsonJE, and KowdleyKV. The hepcidin circuits act: balancing iron and inflammation. Hepatology, 53: 1764–1766, 2011.
27.
Mleczko-SaneckaK, RocheF, da SilvaAR, CallD, D'AlessioF, RagabA, LapinskiPE, UmmanniR, KorfU, and OakesC. Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. Blood, 123: 1574–1585, 2014.
28.
NairzM, HaschkaD, DemetzE, and WeissG. Iron at the interface of immunity and infection. Front Pharmacol, 5: 152, 2014.
29.
NemethE, RiveraS, GabayanV, KellerC, TaudorfS, PedersenBK, and GanzT. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Investig, 113: 1271–1276, 2004.
30.
NemethE, RoettoA, GarozzoG, GanzT, and CamaschellaC. Hepcidin is decreased in TFR2 hemochromatosis. Blood, 105: 1803–1806, 2005.
31.
NemethE, TuttleMS, PowelsonJ, VaughnMB, DonovanA, WardDM, GanzT, and KaplanJ. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 306: 2090–2093, 2004.
32.
NieY, ErionDM, YuanZ, DietrichM, ShulmanGI, HorvathTL, and GaoQ. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol, 11: 492–500, 2009.
33.
NorrisEJ, CulbersonCR, NarasimhanS, and ClemensMG. The liver as a central regulator of hydrogen sulfide. Shock, 36: 242, 2011.
34.
OhG-S, PaeH-O, LeeB-S, KimB-N, KimJ-M, KimH-R, JeonSB, JeonWK, ChaeH-J, and ChungH-T. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264. 7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med, 41: 106–119, 2006.
35.
OhbayashiN, IkedaO, TairaN, YamamotoY, MuromotoR, SekineY, SugiyamaK, HonjohT, and MatsudaT. LIF-and IL-6-induced acetylation of STAT3 at Lys-685 through PI3K/Akt activation. Biol Pharm Bull, 30: 1860–1864, 2007.
36.
PanLL, LiuXH, ZhengHM, YangHB, GongQH, and ZhuYZ. S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in endothelial cells. Int J Cardiol, 155: 327–332, 2012.
37.
ParkCH, ValoreEV, WaringAJ, and GanzT. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem, 276: 7806–7810, 2001.
38.
PaulBD and SnyderSH. H2S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol, 13: 499–507, 2012.
39.
PigeonC, IlyinG, CourselaudB, LeroyerP, TurlinB, BrissotP, and LoréalO. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem, 276: 7811–7819, 2001.
40.
RiversJR, BadieiA, and BhatiaM. Hydrogen sulfide as a therapeutic target for inflammation. Expert Opin Ther Targets, 16: 439–449, 2012.
41.
RodriguezR, JungC-L, GabayanV, DengJC, GanzT, NemethE, and BulutY. Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect Immun, 82: 745–752, 2014.
42.
SakamoriR, TakeharaT, TatsumiT, ShigekawaM, HikitaH, HiramatsuN, KantoT, and HayashiN. STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo. J Gastroenterol, 45: 244–248, 2010.
43.
SethiG, ChatterjeeS, RajendranP, LiF, ShanmugamMK, WongKF, KumarAP, SenapatiP, BeheraAK, and HuiKM. Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo. Mol Cancer, 13: 66, 2014.
44.
ShenY, ShenZ, MiaoL, XinX, LinS, ZhuY, GuoW, and ZhuYZ. miRNA-30 family inhibition protects against cardiac ischemic injury by regulating cystathionine-γ-lyase expression. Antioxid Redox Signal, 22: 224–240, 2014.
45.
ShinD-Y, ChungJ, JoeY, PaeH-O, ChangKC, ChoGJ, RyterSW, and ChungH-T. Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways. Blood, 119: 2523–2532, 2012.
46.
SpillerF, OrricoMI, NascimentoDC, CzaikoskiPG, SoutoFO, Alves-FilhoJC, FreitasA, CarlosD, MontenegroMF, and NetoAF. Hydrogen sulfide improves neutrophil migration and survival in sepsis via K+ ATP channel activation. Am J Respir Crit Care Med, 182: 360–368, 2010.
47.
SuzukiK, OlahG, ModisK, ColettaC, KulpG, GeröD, SzoleczkyP, ChangT, ZhouZ, and WuL. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A, 108: 13829–13834, 2011.
WangR. Hydrogen sulfide: the third gasotransmitter in biology and medicine. Antioxid Redox Signal, 12: 1061–1064, 2010.
50.
WangR. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev, 92: 791–896, 2012.
51.
WangR, CherukuriP, and LuoJ. Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. J Biol Chem, 280: 11528–11534, 2005.
52.
WhitemanM, LiL, RoseP, TanC-H, ParkinsonDB, and MoorePK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal, 12: 1147–1154, 2010.
53.
WrightingDM and AndrewsNC. Interleukin-6 induces hepcidin expression through STAT3. Blood, 108: 3204–3209, 2006.
54.
YuanZ-l, GuanY-j, ChatterjeeD, and ChinYE. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science, 307: 269–273, 2005.
55.
ZanardoRC, BrancaleoneV, DistruttiE, FiorucciS, CirinoG, and WallaceJL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J, 20: 2118–2120, 2006.
56.
ZhengM, QiaoW, CuiJ, LiuL, LiuH, WangZ, and YanC. Hydrogen sulfide delays nicotinamide-induced premature senescence via upregulation of SIRT1 in human umbilical vein endothelial cells. Mol Cell Biochem, 393: 59–67, 2014.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
